E-mail Comment Del.icio.us Digg Reddit Technorati Furl

Results of Clinical Trial in Blood-Based Cancer Detection

Jan 11, 2007 cancer, methylation, news links

BioCangen Inc. has announced the initial results of its clinical validation study of early cancer detection.

    Among the blood samples from 102 patients with solid tumors including lung cancer, colon cancer, breast cancer and stomach cancer, 73 samples were correctly identified as the cancer, showing a 71.6% detection sensitivity. Among the 82 health individuals, only 3 samples were identified as the cancer, indicating a 96.3% specificity.

These results will be further validated with multi-center trials for submission to the FDA. Link

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

This entry was posted on Thursday, January 11th, 2007 at 6:35 am and is filed under cancer, methylation, news links. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.